
- Professional view
- AUA calls ED a marker of cardiovascular disease
- Shared risk factors
- High blood pressure, diabetes, smoking, obesity, high cholesterol
- Usual checks
- Blood pressure, lipids, A1C or glucose, testosterone
- Red flags
- Chest pain, breathlessness on exertion, fainting
Why the penis can be an early warning
An erection is a blood flow event. Arteries in the penis widen, blood fills spongy tissue and veins are compressed so it stays. Anything that damages the lining of blood vessels, such as high blood pressure, high blood sugar, smoking or cholesterol plaque, can interfere with that process.
The arteries supplying the penis are narrow, so a degree of vessel disease that causes no symptoms in the heart may already affect erections. That is the reasoning behind the AUA's position that ED should prompt a look at overall cardiovascular risk.
Conditions that affect both
The National Institute of Diabetes and Digestive and Kidney Diseases lists heart and blood vessel disease, including atherosclerosis, high blood pressure and stroke, among the causes of ED. Diabetes, obesity, smoking and heavy drinking are on the same list.
Some causes are not vascular at all. Low testosterone, thyroid problems, nerve damage from pelvic surgery and many medicines can play a part, as can anxiety, depression and stress. More than one factor is often involved.
- Medicines that can contribute include some antidepressants, blood pressure drugs and diuretics, antihistamines, certain pain relievers including opioids, sedatives and hormone treatments.
- Do not stop a prescribed medicine on your own; ask whether an alternative exists.
What this does not mean
ED does not mean you are about to have a heart attack, and many men with ED have healthy hearts. Stress, relationship strain, alcohol, poor sleep and performance anxiety are common and treatable causes, especially when erections are fine at some times and not others.
The point is not to alarm you. It is to make sure a fixable risk, such as untreated high blood pressure or prediabetes, is not missed while the erection problem gets treated.
Checks that make sense
- Blood pressure, ideally several readings including some at home.
- Cholesterol panel, sometimes with ApoB or lipoprotein(a) for a fuller risk picture.
- A1C or fasting glucose to look for prediabetes or diabetes.
- Morning total testosterone, which the AUA recommends measuring in men with ED.
- A review of smoking, alcohol, sleep and medicines.
- A clear question about chest discomfort, breathlessness or reduced exercise tolerance.
When heart care should come first
The AUA uses established cardiac risk criteria to decide whether a man can be treated for ED without further testing or should see cardiology first. Chest pain, breathlessness with effort, fainting, a recent heart attack or stroke, or poorly controlled blood pressure are reasons to get in-person heart care before any erection treatment.
The Cialis label advises against tadalafil within 90 days of a heart attack, with unstable angina or angina during sex, with significant heart failure in the last six months, with uncontrolled arrhythmias, blood pressure below 90/50 or uncontrolled high blood pressure, or within six months of a stroke. And it must never be combined with nitrates.
Why this matters more for the Triple Action Blend
The Triple Action Blend contains tadalafil plus PT-141 (bremelanotide) and oxytocin. PT-141's FDA-approved form, Vyleesi, temporarily raises blood pressure and is not to be used by people with uncontrolled hypertension or known cardiovascular disease. Vyleesi is approved only for premenopausal women, not for men.
So for men with heart disease, or with significant risk factors that are not yet controlled, the blend is usually not the right choice. Tadalafil alone, after heart risk is addressed, often is.
The encouraging part
Many of the same steps that protect your heart can also improve erections: treating blood pressure and cholesterol, managing blood sugar, stopping smoking, moving more and losing excess weight. Research summarized by the Endocrine Society's journal found that weight loss improved erectile function, though by less than PDE5 inhibitor medicines such as tadalafil.
HealifyMD does not diagnose or manage heart disease, and we will refer you when your history calls for it. Our comprehensive lab panel is $199. The Triple Action Blend is from $149/month and daily tadalafil is from $99/month, confirmed at the eligibility review. The blend is compounded, not FDA-approved, not reviewed by the FDA for safety, effectiveness or quality and not equivalent to any branded product.
Common questions
Is erectile dysfunction a sign of heart disease?
It can be an early sign, which is why the AUA recommends assessing heart risk when ED is diagnosed. Many men with ED do not have heart disease.
Does every man with ED need a cardiology visit?
No. Men at low risk can usually be treated without extra testing. Symptoms or high risk call for cardiology first.
What tests should I have?
Blood pressure, a cholesterol panel, A1C or glucose and a morning testosterone level are a sensible start.
Can I take ED medicine if I have heart disease?
Sometimes, if your cardiologist agrees and you take no nitrates. The Triple Action Blend is usually not suitable because PT-141 raises blood pressure.
Will treating my heart risk improve my erections?
It can help. Weight loss, exercise, not smoking and controlling blood pressure and blood sugar support erectile function.
Does HealifyMD treat heart disease?
No. We check for risk factors and refer you for heart care when needed.
What symptoms after taking ED medicine need emergency care?
Chest pain, fainting, a severe headache, sudden vision or hearing loss or an erection over four hours.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Erectile Dysfunction (ED) GuidelineAmerican Urological Association
- Symptoms & Causes of Erectile DysfunctionNational Institute of Diabetes and Digestive and Kidney Diseases
- Cialis (tadalafil) prescribing informationU.S. Food and Drug Administration
- VYLEESI (bremelanotide injection) prescribing informationU.S. Food and Drug Administration (FDALabel)
- A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management (2017)Journal of Clinical Endocrinology & Metabolism (Endocrine Society)